ScholarIQanswers from OpenAlex
Juno Therapeutics
FunderResearch funding and supported work
Juno Therapeutics is a funder indexed in ScholarIQ from OpenAlex.
What is known about Juno Therapeutics?
ScholarIQrecord summary
biopharmaceutical company
How many works does Juno Therapeutics have?
ScholarIQindexed works
Juno Therapeutics has 422 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Juno Therapeutics?
ScholarIQopenalex
The OpenAlex for Juno Therapeutics is on the source record.
What are the most-cited papers on Juno Therapeutics?
ScholarIQmost cited works
Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial
Giorgio Valabrega, Bhavana Pothuri, Ana Oaknin, Whitney S. Graybill, Ana Beatriz Sánchez, Colleen McCormick, Jean‐François Baurain, Anna V. Tinker, Hannelore Denys, Roisin E. O’Cearbhaill, Sakari Hietanen, Richard G. Moore, Anja Ør Knudsen, Thibault de La Motte Rouge, Florian Heitz, Tally Levy, Whitney York, Divya Gupta, Bradley J. Monk, Antonio González-Martı́n